![]() MOLOGEN MOLOGEN AG is a biotechnology company specializing in the research and clinical development of innovative drugs in the fields of oncology and infectious diseases. | ||
Founding Date | Founding Date 1998 | Founding Date 2002 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Berlin, DE HQ | Locations Princeton, US HQ |
Employees | Employees 4710% decrease | Employees 3540% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) €81k (FY, 2019) | Revenue (est.) $13k (FY, 2023) |
Cost of goods | Cost of goods €2m (FY, 2019) | Cost of goods $13k (FY, 2023) |
Net income | Net income (€10.3m) (FY, 2019) | Net income ($48.1m) (FY, 2023) |

Advaxis is a biotechnology company developing the next generation of cancer immunotherapies.
View company